Defence Therapeutics Inc.
DTC
Ранг среди акций
#29270
Headquartered in Vancouver, Canada, Defence Therapeutics Inc. is a... Headquartered in Vancouver, Canada, Defence Therapeutics Inc. is a biotechnology company founded in 2017. This firm focuses on pioneering biological and biosimilar therapeutic solutions for both cancer and infectious diseases. A cornerstone of its approach is the exclusive ACCUM™ technology, engineered to precisely and safely transport vaccine antigens or antibody-drug conjugates (ADCs) directly to their intended cellular targets. The company's development efforts span several key areas: novel dendritic cell vaccines for various cancers, protein-based vaccines addressing COVID-19 and other infectious ailments, and specialized antibody-drug conjugate products aimed at different cancer types. Defence Therapeutics Inc. adopted its current name in March 2020, having previously operated as Accum Therapeutics Inc.
Цена акции
$0.27889602
Последняя синхронизация: 2026-10-19
Рыночная капитализация
$21.14M
Изменение (1 день)
11.76%
Изменение (1 год)
-52.35%
Страна
CA
Торговля Defence Therapeutics Inc. (DTC)
Категория
Healthcare
Коэффициент P/S для Defence Therapeutics Inc. (DTC)
Коэффициент P/S на 2026 TTM: 0
Согласно последним финансовым отчетам и цене акций Defence Therapeutics Inc., текущий коэффициент P/S (TTM) составляет 0. В конце 2026 он составлял 0.
История P/S для Defence Therapeutics Inc. с 2026 по 2026
Коэффициент P/S в конце каждого года
| Год | P/S | Изменить |
|---|---|---|
| Недостаточно данных для указанных дат. | ||
Коэффициент P/S для аналогичных компаний или конкурентов
| Компания | P/S | Разница P/S | Страна |
|---|---|---|---|
| 10.02 | - |
US
|
|
| 40.55 | - |
US
|
|
| 3.96 | - |
AU
|
|
| - | - |
CH
|
|
| 10.15 | - |
NL
|
